MedTrace Logo

Composite Variability Index Versus Bispectral Index (BIS)

NCT01053611 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2011-03-25

No results posted yet for this study

Summary

The aim of this study is to compare the accuracy of the changes in CVI in response to a standardized noxious stimulus during various targeted pseudo-steady-state concentrations of remifentanil and various steady state level of BIS as guided by propofol effect compartment controlled TCI (closed-loop).

Conditions

  • Sedation During

Interventions

DRUG

propofol + remifentanil 0 ng/ml

remifentanil 0 ng/ml

DRUG

propofol + remifentanil 2 ng/ml

DRUG

propofol + remifentanil 4 ng/ml

DRUG

propofol + remifentanil 6 ng/ml

DRUG

propofol + remifentanil 0 ng/ml

DRUG

propofol + remifentanil 2 ng/ml

DRUG

propofol + remifentanil 6 ng/ml

DRUG

propofol + remifentanil 6 ng/ml

DRUG

propofol + remifentanil 0 ng/ml

DRUG

propofol + remifentanil 2 ng/ml

DRUG

propofol + remifentanil 4 ng/ml

DRUG

propofol + remifentanil 6 ng/ml

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053611 on ClinicalTrials.gov